Zacks33d agobullish
TRT vs. INTT: Which Semiconductor Testing Stock Is the Better Buy?Trio-Tech and InTest ride on different testing and process technology tailwinds, but which looks more compelling now? Let's dive in.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
52last 24h
1808last 7d
298● bullish (7d)
171● bearish (7d)
205publishers
Zacks51d agobullish
Trio-Tech Stock Surges 104.4% in 3 Months: What's Driving the Rally?TRT benefits from strong semiconductor testing demand, new orders and Malaysia expansion, but margin pressure and quarterly losses could weigh on profitability.
Zacks52d agoneutral
Zacks Initiates Coverage of Trio-Tech With Neutral RecommendationDiscover why Zacks rates Trio-Tech as "Neutral," being the first on Wall Street to initiate coverage on the stock. Explore TRT's AI-driven semiconductor testing demand and expanding capacity amid execution risks and semiconductor market cyclicality.
Insider Monkey88d agobullish
Is Trio-Tech International (NYSEAMERICAN:TRT) Among the Best Rising Tech Stocks to Buy According to Hedge Funds?With a one-month return of 185.21%, Trio-Tech International (NYSEAMERICAN:TRT) is among the 8 Best Rising Tech Stocks to Buy According to Hedge Funds. On May 14, Trio-Tech International (NYSEAMERICAN:TRT) stated that it expects increasing demand for its semiconductor back-end testing services, driven by customer programs involving advanced CPU and GPU computing applications as well as electric vehicle […]
24/7 Wall St.89d agoneutral
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely WinnersPresident Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion. ... Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
Exec Edge95d agoneutral
Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral DrugsBy Karen Roman NanoViricides, Inc. (NYSE: NNVC) said the recent outbreak of the hantavirus on a cruise ship highlights the need for broad-spectrum antiviral drugs such as NV-387. The hantavirus gets into the lungs through droplets of cough or spit from an infected person and incidents are becoming more common on cruises, making a global […]
Exec Edge100d agoneutral
NanoViricides to Participate at D. Boral Capital Global Conference in NYCBy Karen Roman NanoViricides, Inc. (NYSE: NNVC) said it will participate at the D. Boral Capital Global Conference, to be held on May 7, 2026, at The Plaza Hotel in New York City. The company’s President and Executive Chairman, Anil R. Diwan, PhD, will offer one-on-one meetings on the same day from 9:45AM to 2:45PM ET. […]